Magyar Hypertonia Társaság

Blood Pressure Lowering and Risk of Cancer: Individual Participant-Level Data Meta-Analysis and Mendelian Randomization Studies

Nazarzadeh M,  Copland E, Byrne KS, Canoy D, Bidel Z, Woodward M, et al. Blood Pressure Lowering Treatment Trialists’ Collaboration

JACC: CardioOncology, előzetes elektronikus közlés: 2025.05.13. https://doi.org/10.1016/j.jaccao.2025.03.005

Heart rate-lowering drugs and outcomes in hypertension and/or cardiovascular disease: a meta-analysis

Sanidas E, Böhm M, Oikonomopoulou I, Dinopoulou P, Papadopoulos D, Michalopoulou H, et al.

European Heart Journal, előzetes elektronikus közlés: 2025.04.25. https://doi.org/10.1093/eurheartj/ehaf291

Olsen E, Søraas CL, Schmieder RE, Jamerson K, MacDonald TM, Mancia G, et al. Valsartan Antihypertensive Long-term Use Evaluation Trial (VALUE) Investigators

American Journal of Hypertension, 2025; előzetes elektronikus közlés: 2025.05.21. hpaf093, https://doi.org/10.1093/ajh/hpaf093

Systolic blood pressure targets below 120 mm Hg are associated with reduced mortality: A meta-analysis

Bergmann F, Prager M, Lena Pracher, Rebecca Sawodny, Gloria M. Steiner-Gager, Bernhard Richter, et al.

J Intern Med. Előzetes elektronikus közlés: 2025.03.05.  https://doi.org/10.1111/joim.20078

Treatment in the First Month After Hypertension Diagnosis Improves Blood Pressure Control

Barrett RB, Riesser B, Martin B, Sachdev N, Sutherland SE, Brent M

Hypertension. 2025;82(6): 1129-1136. https://doi.org/10.1161/HYPERTENSIONAHA.124.23508

Obesity, Visceral Adipose Tissue, and Essential Hypertension: Evidence From a Mendelian Randomization Study and Mediation Analysis

Cheng C, Li Z, Su Y,  Sun J-Y,  Xu C-H,  Kong X-Q, Sun W, et al.

J Clin Hypertension. Előzetes elektronikus közlés: 2025.04.21. https://doi.org/10.1111/jch.70045

Bedtime vs Morning Antihypertensive Medications in Frail Older Adults: The BedMed-Frail Randomized Clinical Trial. 

Garrison SR, Youngson ERE, Perry DA,  Campbell FN, Korownyk CS, Lee A. Greenet al.

JAMA Netw Open. 2025;8(5):e2513812. doi:10.1001/jamanetworkopen.2025.13812

Antihypertensive Medication Timing and Cardiovascular Events and Death: The BedMed Randomized Clinical Trial. 

Garrison SR, Bakal JA, Kolber MR,  Korownyk CS, Green LA,  Kirkwood JEM, et al.

JAMA. Előzetes elektronikus közlés: 2025.05.12. doi:10.1001/jama.2025.4390

Failure of Antihypertensive Treatment to Restore Normal Sympathetic Activity

Quarti-Trevano F, Seravalle G, Facchetti R, Tsioufis K, Dimitriadis K,  Manta E,

Hypertension. https://doi.org/10.1161/HYPERTENSIONAHA.124.24429

Global Effect of Cardiovascular Risk Factors on Lifetime Estimates

Global Cardiovascular Risk Consortium; Magnussen C, Alegre-Diaz J, Al-Nasser LA, Amouyel P, Aviles-Santa L, Bakker SJ, et al.

N Engl J Med. Előzetes eleketronikus közlés: 2025.03.30. doi: 10.1056/NEJMoa2415879.